Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer, Published online: 09 November 2017; doi:10.1038/bjc.2017.279

http://ift.tt/2zKFBt0